A decade of research on the natural history of HIV infection: Part 2. Cofactors

Clinical and Investigative Medicine

Volumn 19, Issue 2, 1996, Pages 121-130

  Strathdee, Steffanie A ^a,b   Hogg, Robert S ^a   O'Shaughnessy, Michael V ^a,b   Montaner, Julio S G ^a,b   Schechter, Martin T ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

DISEASE COURSE; GENITAL ULCER; HEPATITIS C; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; STRAIN DIFFERENCE; VIRUS STRAIN; VIRUS TRANSMISSION;

COMORBIDITY; DEMOGRAPHY; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; NUTRITION PHYSIOLOGY; PHENOTYPE; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS; VIRUS DISEASES;

EID: 0029988396     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. Brookmeyer R, Gail MH, Polk BR: The prevalent cohort study and the acquired immunodeficiency virus. Am J Epidemiol 1987; 126: 14-24
2. Archibald CP, Schechter MT, Le TN et al: Evidence for a sexually transmitted cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men. Epidemiology 1992; 3: 203-209
3. Chang Y, Cesarman E, Pessin MS et al: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869
4. Levy JA: HIV pathogenesis and long-term survival. AIDS 1993; 7: 1401-1410
5. Pang S, Shlesinger Y, Daar ES et al: Rapid generation of sequence variation during primary HIV-1 infection. AIDS 1992; 6: 453-460
6. Schuitemaker H, Koot M, Kootstra NA et al: Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J Virol 1992; 66: 1354-1360
7. Koot M, Keet IPM, Aster HVV et al: Prognostic value of HIV-1 syncytium-inducing phenotype for rate of CD4+ cell depletion and progression to AIDS. Ann Intern Med 1993; 118: 681-688
8. Boucher CAB, Lange JMA, Miedema F et al: HIV-1 biological phenotype and development of zidovudine resistance in relation to development progression in asymptomatic individuals during treatment. AIDS 1992; 6: 1259-1264
9. Sheppard HW, Lang W, Ascher MS et al: The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS 1993; 7: 1159-1166
10. 6/l but free of AIDS-defining clinical disease. AIDS 1994; 8: 1577-1583
11. Spijkerman IJB, Koot M, Prins M et al: Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. AIDS 1995; 9: 1085-1092
12. Verhofstede C, Reniers S, Van Wanzeele F et al: Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease. AIDS 1994; 8: 1421-1427
13. Richman DD, Grimes JM, Lagakos SW: Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. J Acquir Immune Defic Syndr 1990; 3: 743-746
14. Montaner JSG, Singer J, Schlechter MTS et al: Clinical correlates of in vitro HIV-1 resistance to zidovudine: results of the multicentre Canadian AZT Trial. AIDS 1993; 7: 189-196
15. Wainberg MA, Montaner JSG: After the Concorde Trial: Where do we go from here? Grand Rounds Infect Dis 1994; 4: 9-11
16. Wainberg MA, Salomon H, Gu Z et al: Development of HIV-1 resistance to (-)2′-deoxy-3′-thiacytidine in patients with AIDS or advanced AIDS-related complex. AIDS 1995; 9: 351-357
17. 3. [abstract 358B] 10th International Conference on AIDS, Yokohama, Japan, Aug 7-12, 1994
18. Latif AS, Katzenstein DA, Bassett MT et al: Genital ulcers and transmission of HIV among couples in Zimbabwe. AIDS 1989; 3: 519-523
19. Plummer FA, Simonsen JN, Cameron DW et al: Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163: 233-239
20. Laga M, Abib M, Mayimona K et al: Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7: 95-102
21. Kreiss JK, Koech D, Plummer FA et al: AIDS virus infection in Nairobi prostitutes: spread of the epidemic to East Africa. N Engl J Med 1986; 314: 414-418
22. Cameron DW, Simonsen JN, D'Costa L et al: Female-to-male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989; 2: 403-407
23. Stamm WE, Handfield HH, Rompalo AM et al: The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260: 1429-1433
24. Holmberg SD, Stewart JA, Gerber AR et al: Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988; 259: 1048-1050
25. Stein DS, Graham NMH, Park LP et al: The effect of interactions of acyclovir with zidovudine on progression to AIDS and survival in the Multicenter Cohort Study. Ann Intern Med 1994; 121: 100-108
26. Gallant JE, Moore RD, Keruly J et al: Lack of association between acyclovir use and survival in patients with advanced HIV disease treated with zidovudine. J Infect Dis 1995; 172: 346-352
27. Collier AC, Schoenfeld DA, Bourland D et al: Prospective comparative study of acyclovir (ACV) and zidovudine (ZDV) versus ZDV alone in patients with AIDS, [abstract 383] 2nd National Conference on Human Retroviruses and Related Infections, Washington, Jan 29-Feb 2, 1995
28. Biggar RJ, Goedert JJ, Hoofnagle J: Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N Engl J Med 1987; 316: 630-631
29. Eskild A, Magnus P, Petersen G et al: Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS 1992; 6: 571-574
30. Waite J, Gilson RJC, Weller IVD et al: Hepatitis B virus reactivation or reinfection associated with HIV-1 infection. AIDS 1988; 2: 443-448
31. Coates RA, Farewell VT, Raboud J et al: Cofactors of progression to acquired immunodeficiency syndrome in a cohort of male sexual contacts of men with human immunodeficiency virus disease. Am J Epidemiol 1990; 132: 717-722
32. Schlechter MT, Craib KJP, Le TN et al: Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men. AIDS 1989; 3: 347-353
33. Eyster ME, Alter JK, Aledort LM et al: Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 1991; 115: 764-768
34. Lo S-C, Shih JW-K, Yang N-Y et al: A novel virus-like agent in patients with AIDS. Am J Trop Med Hyg 1989; 40: 213-226
35. Lo SC, Hayes MM, Wang RY et al: Newly discovered mycoplasma isolated from patients infected with HIV. Lancet 1991; 338: 1415-1418
36. Lusso P, Gallo RC: Human herpesvirus 6 in AIDS. Immunol Today 1995; 16: 67-71
37. Lusso P, Markham PD, Tschachler E et al: In vitro cellular tropism of human lymphotrophic virus (human herpesvirus-6). J Exp Med 1988; 167: 1659-1670
38. Dupin N, Grandadam M, Calvez V et al: Herpes-virus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995; 345: 761-762
39. Huang YQ, Li JJ, Kaplan MH et al: Human herpes-virus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995; 345: 759-761
40. Boshoff C, Whitby D, Hatziioannou T et al: Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995; 345: 1043-1044
41. Cohen J: Controversy: Is KS really caused by new herpesvirus? Science 1995; 268: 1847-1848
42. Veugelers PJ, Strathdee SA, Moss AR et al: Is the human immunodeficiency virus-related Kaposi's sarcoma epidemic coming to an end? Insights from the Tricontinental Seroconverter Study. Epidemiology 1995; 6: 382-386
43. Lundgren JD, Melbye M, Pedersen C et al: Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. Am J Epidemiol 1995; 141: 652-658
44. Jones JL, Hanson DL, Chu SY et al: AIDS-associated Kaposi's sarcoma. Science 1995; 267: 1078-1079
45. O'Brien WA, Grovit-Ferbas K, Namazi A et al: Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995; 86: 1082-1089
46. Steel CM, Ludlam CA, Beatson D et al: HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet 1988; 1: 1185-1188
47. Kaslow RA, Duquesnoy R, Van Raden M et al: A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. Lancet 1990; 335: 927-930
48. Hoff C, James WC, Hester RB et al: Signs of cellular immunosuppression correlate with HLA-DR phenotypes in healthy HIV-negative homosexuals: preliminary findings. Hum Biol 1991; 63: 125-135
49. Hoff C, Peterson RDA: Lymphocyte alloantigenic challenge as a potential cofactor in HIV infection and progression to AIDS. Am J Hum Biol 1990; 2: 419-427
50. Mann D, Carrington M, O'Donnell M et al: Selected HLA class I and II alleles are associated with relative rates of disease progression in HIV-1 infection. [abstract WS-A07-6] 9th International Conference on AIDS, Berlin, June 6-11, 1993
51. Itescu S, Mathur-Wagh U, Skovron ML et al: HLA-B35 is associated with accelerated progression to AIDS. J Acquir Immune Defic Syndr 1991; 5: 37-45
52. Schrager LK, Young JM, Fowler MG et al: Long-term survivors of HIV-1 infection: definitions and research challenges. AIDS 1994; 8 (suppl 1): S95-S108
53. Itescu S, Brancato LJ, Winchester R: A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 1989; 2: 466-468
54. Kuntz ME, Brüster HT: Time-dependent variation of HLA-antigen-frequencies in HIV-1 infection (1983-1988). Tissue Antigens 1989; 34: 164-169
55. Hentges F, Hoffmann A, Oliveira de Araujo F et al: Prolonged clinically asymptomatic evolution after HIV-1 infection is marked by the absence of complement C4 null alleles at the MHC. Clin Exp Immunol 1992; 88: 237-242
56. Louie LG, Newman B, King MC: Influence of host genotype on progression to AIDS among HIV-infected men. J Acquir Immune Defic Syndr 1991; 4: 814-818
57. Buchbinder SP, Katz MH, Hessol NA et al: Long-term HIV-1 infection without immunologic progression. AIDS 1994; 8: 1123-1128
58. Goedert JJ, Neuland CY, Wallen WC et al: Amyl nitrite may alter T lymphocytes in homosexual men. Lancet 1982; 1: 412-416
59. Kaslow RA, Blackwelder WC, Ostrow DG et al: No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1 positive individuals. JAMA 1989; 261: 3424-3429
60. Veugelers PJ, Page KA, Tindall B et al: Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am J Epidemiol 1994; 140: 747-758
61. Royce RA, Winkelstein WW Jr: HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men's Health Study. AIDS 1990; 4: 327-333
62. Niemann RB, Fleming J, Coker RJ et al: The effect of cigarette smoking on the development of AIDS in HIV-1 positive individuals. AIDS 1993; 7: 705-710
63. Craib KJP, Schechter MT, Montaner JSG et al: The effect of cigarette smoking on lymphocyte subsets and progression to AIDS in a cohort of homosexual men. Clin Invest Med 1992; 15: 301-308
64. Fong LW, Read S, Wainberg MA et al: Alcoholism and rapid progression to AIDS after seroconversion. Clin Infect Dis 1994; 19: 337-338
65. Boulton M: Methodological issues in HIV/AIDS social research: recent debates, recent developments. AIDS 1993; 7 (suppl 1): S249-S255
66. Phillips AN, Sabin CA, Mocroft A: Active drug injecting and progression of HIV infection. AIDS 1994; 8: 385-386
67. Mientjes GHC, Van Ameijden EJC, Van den Hoek AJAR et al: Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment. AIDS 1993; 7: 1363-1370
68. Ronald PJM, Robertson JR, Elton RA: Continued drug use and other cofactors for progression to AIDS among injecting drug users. AIDS 1994; 8: 339-343
69. Vlahov D, Munoz A, Solomon L et al: Comparison of clinical manifestations of HIV infection between male and female injecting drug users. AIDS 1994; 8: 819-823
70. Jason J, Lui K-J, Ragni MV et al: Risk of developing AIDS in HIV-infected cohorts of hemophiliac and homosexual men. JAMA 1989; 261: 725-727
71. Carré N, Deveau C, Belanger F et al: Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. AIDS 1994; 8: 797-802
72. Italian Register for HIV Infection in Children: Features of children perinatally infected with HIV-1 surviving longer than 5 years. Lancet 1994; 343: 191-195
73. Moss AR, Bacchetti P, Osmond D et al: Seropositivity for HIV and the development of AIDS or ARC: three year follow-up of the San Francisco General Hospital cohort. BMJ 1988; 296: 745-750
74. Veugelers PJ, Strathdee SA, Tindall B et al: Increasing age is associated with faster progression to neoplasms but not opportunistic infections in HIV-infected homosexual men. AIDS 1994; 8: 1471-1475
75. Goedert JJ, Kesler CM, Aledort LM et al: A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989; 321: 1141-1148
76. Phillips AN: Studies of prognostic markers in HIV infection: implications for pathogenesis. AIDS 1991; 6: 1391-1394
77. Blaxhult A, Granath F, Lidman K et al: The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS 1990; 4: 125-129
78. Kopec-Schrader E, Tindall B, Learmont J et al: Development of AIDS in people with transfusion-acquired HIV infection. AIDS 1993; 7: 1009-1013
79. Mariotto AB, Mariotti S, Pezzotti P et al: Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol 1992; 135: 428-437
80. Hessol NA, Koblin BA, Van Griensven GJP et al: Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol 1994; 139: 1077-1087
81. Polk BF, Fox R, Brookmeyer R et al: Predictors of the Acquired Immunodeficiency Syndrome developing in a cohort of seropositive homosexual men. N Engl J Med 1987; 316: 61-66
82. Keet IPM, Krijnen P, Koot M et al: Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993; 7: 51-57
83. Coates TJ, Stall RD, Catania JA et al: Behavioural factors in the spread of HIV infections. AIDS 1988; 2 (suppl 1): 239-246
84. Hogg RS, Craib KJP, Willoughby BC et al: Sociodemographic correlates for risk-taking behaviour among seronegative men. Can J Public Health 1993; 84: 432-436
85. Curtis JR, Patrick DL: Race and survival time with AIDS: a synthesis of the literature. Am J Public Health 1993; 83: 1425-1428
86. Blum S, Singh TP, Gibbons J et al: Trends in survival among persons with acquired immunodeficiency syndrome in New York City: the experience of the first decade of the epidemic. Am J Epidemiol 1994; 139: 351-361
87. Moore RD, Stanton D, Gopalan R et al: Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med 1994; 330: 763-768
88. Gorter RW, Vranizan KM, Osmond DH et al: Differences in laboratory values in HIV infection by sex, race, and risk group. AIDS 1992; 6: 1341-1347
89. Hogg RS, Strathdee SA, Craib KJP et al: Lower socioeconomic status and shorter survival following HIV infection. Lancet 1994; 344: 1120-1124
90. Simon PA, Hu DJ, Diaz T et al: Income and AIDS rates in Los Angeles County. AIDS 1995; 9: 281-284
91. Kotler DP, Wang J, Pierson R: Studies of body composition in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 1985; 42: 1255-1265
92. Hommes MJT, Romijn JA, Godfried KJM et al: Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism 1990; 39: 1186-1190
93. Kotler DP, Tierney AR, Brenner SK et al: Preservation of short-term energy balance in clinically stable patients with AIDS. Am J Clin Nutr 1990; 51: 7-13
94. Chlebowski RT, Grosvenor MB, Bernard NH et al: Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol 1985; 102: 619-622
95. Semba RD, Miotti PG, Chiphangwi JD et al: Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancetr 1994; 343: 1593-1597
96. Tang AM, Graham NMH, Kirby AJ et al: Dietary micronutrient intake and risk of progression to Acquired Immunodeficiency Syndrome (AIDS) in Human Immunodeficiency Virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol 1993; 138: 937-951
97. Abrams B, Duncan D, Hetz-Picciotto I: A prospective study of dietary intake and Acquired Immune Deficiency Syndrome in HIV-seropositive homosexual men. J Acquir Immune Defic Syndr 1993; 6: 949-958
98. Baum MK, Mantero-Atienza E, Shor-Posner G et al: Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. J Acquir Immune Defic Syndr 1991; 4: 1122-1132
99. Slusarczyk R: The influence of the human immunodeficiency virus on resting energy expenditure. J Acquir Immune Defic Syndr Hum Retrovir 1994; 7: 1025-1027
100. Hogg RS, Zadra JN, Chan-Yan C et al: Analysis of nutritional intake in a cohort of homosexual men. J Acquir Immune Defic Syndr Hum Retrovir 1995; 9: 162-167
101. Voigt R, Hogg RS, Craib KJP et al: Socioeconomic characteristics are associated with rate of weight loss in homosexual men. [abstract] 10th International Conference on AIDS. Yokohama, Japan, Aug 7-12, 1994
102. Jain V, Chandra R: Does nutritional deficiency predispose to acquired immune deficiency syndrome? Nutr Res 1984; 4: 537-543
103. Semba RD, Graham NMH, Caiaffa WT et al: Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 1993; 153: 2149-2154
104. Karter DL, Karter AJ, Yarrish R et al: Vitamin A deficiency in non-vitamin-supplemented patients with AIDS: a cross-sectional study. J Acquir Immun Defic Syndr Hum Retrovir 1995; 8: 199-203
105. Cassel J: The contribution of the social environment to host resistance. Am J Epidemiol 1976; 104: 107-123
106. Berkman LF, Syme SL: Social networks, host resistance and mortality: a nine-year follow-up study of Alameda County residents. Am J Epidemiol 1979; 108: 186-204
107. Atkinson JH Jr, Grant I, Kennedy CJ et al: Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. Arch Gen Psychiatry 1988; 45: 859-864
108. Kessler RC, O'Brien K, Joseph JG et al: Effects of HIV infection, perceived health and clinical status on a cohort at risk for AIDS. Soc Sci Med 1988; 27: 569-578
109. Kessler RC, Foster C, Joseph J et al: Stressful life events and symptom onset in HIV infection. Am J Psychiatry 1991; 148: 733-738
110. Rabkin JG, Williams JBW, Remien RH et al: Depression, distress, lymphocyte subsets and human immunodeficiency virus symptoms on two occasions in HIV-positive homosexual men. Arch Gen Psychiatry 1991; 48: 111-119
111. Antoni MH, Baggett L, Ironson G et al: Cognitive-behavioural stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. J Consult Clin Psychol 1991; 59: 906-915
112. Solomon GF, Temoshok S, O'Leary A et al: An intense psychoimmunologic study of long-surviving persons with AIDS. Ann N Y Acad Med 1987; 496: 647-655
113. Sahs JA, Goetz R, Reddy M et al: Psychological distress and natural killer cells in gay men with and without HIV infection. Am J Psychiatry 1994; 151: 1479-1484
114. Blomkvist V, Theorell T, Jonsson H et al: Psychosocial self-prognosis in relation to mortality and morbidity in hemophiliacs with HIV infection. Psychother Psychosom 1994; 62: 185-192
115. Keet IPM, Krol A, Klein MR et al: Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. J Infect Dis 1994; 169: 1236-1243
116. O'Brien K, Wortman CB, Kessler RC et al: Social relationships of men at risk for AIDS. Soc Sci Med 1993; 36: 1161-1167
117. Willoughby BC, Hogg RS, Strathdee SA et al: Is low social support a risk factor for subsequent HIV disease progression? [abstract] 10th International Conference on AIDS, Yokohama, Japan, Aug 7-12, 1994
118. Cunningham AL, Dwyer DE, Dowton DN: Viral markers in HIV infection and AIDS. J Acquir Immune Defic Syndr 1993; 6 (suppl 1): S32-S35